Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
3.620
-0.180 (-4.74%)
At close: Apr 28, 2026, 4:00 PM EDT
3.600
-0.020 (-0.55%)
After-hours: Apr 28, 2026, 6:38 PM EDT
LIXT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 4.85 | 2.85 | 4.19 | 4.96 | 4.98 | |
| Research & Development | 0.25 | 0.73 | 0.9 | 1.35 | 1.74 | |
| Operating Expenses | 5.11 | 3.57 | 5.09 | 6.31 | 6.72 | |
| Operating Income | -5.11 | -3.57 | -5.09 | -6.31 | -6.72 | |
| Interest Expense | -0.01 | -0.02 | -0.02 | -0.01 | -0.01 | |
| Interest & Investment Income | 0.01 | 0.01 | 0.02 | 0.01 | 0 | |
| Currency Exchange Gain (Loss) | 0 | -0 | 0 | -0 | -0 | |
| Other Non Operating Income (Expenses) | -0.9 | - | - | - | - | |
| Pretax Income | -6.01 | -3.59 | -5.09 | -6.31 | -6.73 | |
| Net Income | -6.01 | -3.59 | -5.09 | -6.31 | -6.73 | |
| Preferred Dividends & Other Adjustments | 0.07 | - | - | - | - | |
| Net Income to Common | -6.08 | -3.59 | -5.09 | -6.31 | -6.73 | |
| Shares Outstanding (Basic) | 5 | 2 | 2 | 2 | 1 | |
| Shares Outstanding (Diluted) | 5 | 2 | 2 | 2 | 1 | |
| Shares Change (YoY) | 115.21% | 17.41% | 21.10% | 17.41% | 19.48% | |
| EPS (Basic) | -1.26 | -1.59 | -2.66 | -3.99 | -4.99 | |
| EPS (Diluted) | -1.26 | -1.59 | -2.66 | -3.99 | -4.99 | |
| Free Cash Flow | -3.17 | -3.16 | -4.29 | -4.61 | -4.14 | |
| Free Cash Flow Per Share | -0.65 | -1.41 | -2.24 | -2.92 | -3.08 | |
| EBIT | -5.11 | -3.57 | -5.09 | -6.31 | -6.72 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.